Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

21.76
BATS BZX Real-Time Price
As of 10:28am ET
 +0.275 / +1.28%
Today’s Change
3.36
Today|||52-Week Range
27.79
+67.09%
Year-to-Date
No recent news for Achaogen Inc.

Today’s Trading

Previous close21.48
Today’s open21.65
Day’s range21.26 - 21.80
Volume4,717
Average volume (3 months)929,256
Market cap$877.4M
Dividend yield--
Data as of 10:28am ET, 06/28/2017

Growth & Valuation

Earnings growth (last year)-101.34%
Earnings growth (this year)+11.40%
Earnings growth (next 5 years)--
Revenue growth (last year)+60.29%
P/E ratioNM
Price/Sales7.39
Price/Book7.17

Competitors

 Today’s
change
Today’s
% change
ZIOPZIOPHARM Oncology In...-0.09-1.47%
ACORAcorda Therapeutics ...+0.15+0.79%
CARACara Therapeutics In...+0.48+1.82%
BHVNBiohaven Pharmaceuti...-0.01-0.04%
Data as of 10:28am ET, 06/28/2017

Financials

Next reporting dateAugust 8, 2017
EPS forecast (this quarter)-$0.63
Annual revenue (last year)$41.8M
Annual profit (last year)-$71.2M
Net profit margin-170.51%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
Chief Executive Officer &
Director
Kenneth J. Hillan
President &
Chief Operating Officer
Blake Wise
Corporate headquarters
South San Francisco, California

Forecasts